Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study (Q46744879)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study |
scientific article |
Statements
1 reference
Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study (English)
1 reference
Marta Osorio
1 reference
Elías Gracia
1 reference
Edmundo Rodríguez
1 reference
Giselle Saurez
1 reference
Maria Del Carmen Arango
1 reference
Elena Noris
1 reference
Adriana Torriella
1 reference
Alejandro Joan
1 reference
Erasmo Gómez
1 reference
Lorenzo Anasagasti
1 reference
Jorge Luis González
1 reference
María de Los Angeles Melgares
1 reference
Imilla Torres
1 reference
Joel González
1 reference
Dayamí Alonso
1 reference
Enrique Rengifo
1 reference
Adriana Carr
1 reference
Rolando Pérez
1 reference
Luis Enrique Fernández
1 reference
2 January 2007
1 reference
7
1 reference
4
1 reference
488-495
1 reference
Identifiers
1 reference
1 reference